期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

β受体阻滞剂治疗心衰的研究进展 被引量：2

Progress in Treatment of Heart Failure with β-Adrenergic Receptor-blockers
下载PDF
导出
摘要 本文综述了β受体阻滞剂在充血性心力衰竭治疗的研究进展,详细解释了β受体阻滞剂在治疗心衰的作用机理。分析了不同类型的β受体阻滞剂,并进一步提出β3受体阻滞剂在未来治疗心衰的深远意义,以及介绍了治疗心衰联合使用阻滞剂以及激动剂的新方法。 This article reviews the recent investigation of treating congestive heart failure by using β-adrenergic receptor blockers,and the mechanisms that how β-blocker therapy can be used by CHF patients. Different types of β-adrenergic receptor blockers have been introduced,and new development of treadrenergic receptor blockers such as β3-blocker is also mentioned in this review,as well as the new method of treating heart failure by using the combination of adrenergic agonists and antagonists.
作者 李小蓓 王礼琛
机构地区 中国药科大学有机化学教研室
出处 《海峡药学》 2006年第4期1-4,共4页 Strait Pharmaceutical Journal
关键词 Β受体阻滞剂 心力衰竭 β-Adrenergic receptor-blockers,Heart failure
分类号 R978.11 [医药卫生—药品]
  • 相关文献

参考文献22

  • 1孙忠实,朱珠.β受体阻滞剂在慢性心力衰竭的应用[J].中国药学杂志,2000,35(2):75-78. 被引量：23
  • 2Satwani S,Dec GW,et al.β-adrenergic blockers in heart failure:Review of mechanisms of action and clinical outcomes[J].Journal of Cardiovascular Pharmacology and Therapeutics,2004,9(4),243～255.
  • 3那开宪,余平.β受体阻滞剂在慢性心力衰竭治疗中的一些误区[J].中国临床医生杂志,2005,33(3):54-57. 被引量：3
  • 4MERIT HF Study Group.Effect of metoprolol CR/XL in chronic heart failure:metoprolol CR/XL Randomized Inetrvention Trial in Congestive Heart Failure[J].Lancet,1999,253:2001～207.
  • 5CIBIS-Ⅱ Investigators and Committees.The Cardiac Insuffciency Bissoporolol Study Ⅱ(CIBIS Ⅱ):a randomizde trial[J].Lancet,1999,353:9～13.
  • 6Ellison K E,Gandhi G.Optimising the use of β-adrenoceptor antagonists in coronary artery disease[J].Drugs,2005,65(6),787～797.
  • 7Eichhom EJ,Bristow MR.Medical therapy can improve the biological properties the chronically failingheart:a new era in the treatment of heart failure[J].Circulation,1996,94:2258～2296.
  • 8Bropht JN,Joseph L,Rouleaa JL.β-blockers in congestive heart failure-A Rayesiaa meta-analysis[J].Ann Intern Med,2001,134:550～560.
  • 9陈忠,袁永,刘兆昶.β受体阻滞剂在充血性心力衰竭治疗中的应用[J].中国心血管杂志,2003,8(5):372-373. 被引量：14
  • 10Peter M,William AP.Funamental consideration of β-adrenoceptor subtypes in human heart failure[J].Trends in Pharmacol Sci,2005,26(7),368～375.

二级参考文献84

  • 1陈修 等.心血管药理学．第二版[M].北京：人民卫生出版社,1996.167-168.
  • 2Emorine LJ,Marullo S,Briend-Sutren MM,et al.Molecular characterization of the human β3-adrenergic receptor.Science,1989,245:1118-1121.
  • 3Pelat M,Verwaerde P,Galitzky J,et al.High isoproterenol doses are required to activate β3-adrenoceptor-mediated function in dogs.J Pharmacol Exp Ther,2003,304:246-253.
  • 4Naltel F,Bonin H,Emorine LJ,et al.The human β3-adrenergic receptor is resistant to short term agonist-promoted desensitization.Mol Pharmacol,1993,43:548-555.
  • 5Morimoto A,Hasegawa H,Cheng HJ,et al.Endogenous β3-adrenoreceptor activation contributes to left ventricular and cardiomyocyte dysfunction in heart failure.Am J Physiol heart Circ Physiol,2004,286:H2425-H2433.
  • 6Gauthier C,Leblais V,Moniotte S,et al.The negative inotropic action of catecholamines:role of β3-adrenoceptors.Can J Physiol Pharmacol,2000,78:681-690.
  • 7Gauthier C,Tavernier G,Charpentier F,et al.Functional β3-adrenoceptor in the human heart.J Clin Invest,1996,98:556-562.
  • 8Moniotte S,Kobzik L,Feron O,et al.Upregulation of β3-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium.Circulation,2001,103:1649-1655.
  • 9Elies R,Ferrari I,Wallukat G,et al.Structural and functional analysis of the B cell epitopes recognized by anti-receptor autoantibodies in patients with Chagas′ disease.J Immunol,1996,157:403-411.
  • 10Chiale PA,Rosenbaum M,Elizari V,et al.High prevalence of antibodies against β1- and β2-adrenergic receptors in patients with primary electrical cardiac disturbances.J Am Coll Cardiol,1995,26:864-869.

共引文献88

同被引文献12

  • 1李荣,易岂建,钱永如,刘晓燕.卡维地洛对心力衰竭时兰尼碱受体的作用[J].中华儿科杂志,2005,43(8):603-607. 被引量：7
  • 2Waagstein F, Bristow MR, Swedberg K, et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy [J]. Lancet,1993,342(8 885):1 441.
  • 3Dalla Libera L, Ravara B, Angelini A, et al. Beneficial effects on skeletal muscle of the angiotensin Ⅱ type 1 receptor blocker irbesartan in experimental heart failure [ J ]. Circulation ,2001,103 ( 17 ) :2 195.
  • 4Campian ME, Hardziyenka M, Michel MC, et al. How valid are animal models to evaluated treatment for pulmonary hypertension[ J]. Naunyn-Schmiedeberg's Arch Pharmacol, 2006,373 ( 6 ) : 391.
  • 5Qvigstad E, Sjaastad I, Bφkenes J, et al. Carvedilol blockade of α1-and β adrenoceptor induced inotropic responses in rats with congestive heart failure [ J ].Eur J Pharmacol, 2005, 516(1): 51.
  • 6Wei S, Chow LT, Sanderson JE. Effect of carvedilol in comparison with metoprolol on myocardial collagen postin farction[J].J Am Coll Cardiol,2000, 36( 1 ) :276.
  • 7Nagaya N ,Ando M ,Oya H ,et al. Plasma brain natriuretic peptide as a non-invasive marker for efficacy of pulmonary thromboendarterectomy [ J ]. Ann Thorac Surg,2002,74 ( 1 ) : 180.
  • 8Bristow MR. Mechanism of action of β-blocking agents in heart failure[J]. Am J Cardiol,1997, 80(11A) :26L.
  • 9Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction:A randomized clinical trial[J].South China Journal of Cardiology,2013,14(1):77-78. 被引量：60
  • 10刘文澜.β-受体阻滞剂在心血管疾病中的应用进展[J].现代诊断与治疗,2013,24(13):2936-2938. 被引量：3

引证文献2

二级引证文献17

海峡药学
2006年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部